The preclinical trial process typically involves several key steps. First, researchers conduct initial screening to identify potential candidates. This is followed by pharmacokinetic and pharmacodynamic studies to understand how the drug is absorbed, distributed, metabolized, and excreted in the body. Next, efficacy studies are performed to evaluate the treatment's effectiveness against cancer cells. Finally, toxicology studies are conducted to assess any adverse effects.
